The present invention is a method for effecting rapid improvement in cognition in subjects suffering from conditions or diseases related to the A.beta. peptide, including Alzheimer's disease, Down's syndrome, cerebral amyloid angiopathy, mild cognitive impairment, and the like. The method comprises administering anti-A.beta. antibodies to the subject, especially antibodies having a high affinity for soluble forms of A.beta.. X-15240

 
Web www.patentalert.com

< Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules

< Uses of agonists and antagonists to modulate activity of TNF-related molecules

> Therapeutic agents with decreased toxicity

> Cloning of chicken anemia virus DNA

~ 00251